The state of knowledge on the expression and function of PKD in gliomas is limited, although recent studies have shown that ZKK3 inhibits the activity of PKD1 in glial cell lines [97] as well as that of PKD isoforms under various tumour oxygen conditions [102]. This evidence concerns the gene PRKD1 and central nervous system cancer.